Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study.

Authors : Longo-Muñoz F, Castellano D, Alexandre J, Chawla SP, Fernández C, Kahatt C, Alfaro V, Siguero M, Zeaiter A, Moreno V, Sanz-García E, Awada A, Santaballa A, Subbiah V
Year : 2022
Journal : Eur J Cancer
Volume : 172
Pages : 340-348

Corrigendum to 'p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib'[Eur J of Cancer 55 (2016) 98-110].

Authors : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Salès F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G
Year : 2022
Journal : Eur J Cancer
Volume : 175
Pages : 336-338

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.

Authors : Thouvenin J, Van Marcke C, Decoster L, Raicevic G, Punie K, Vandenbulcke M, Salgado R, Van Valckenborgh E, Maes B, Joris S, Steichel DV, Vranken K, Jacobs S, Dedeurwaerdere F, Martens G, Devos H, Duhoux FP, Rasschaert M, Pauwels P, Geboes K, Collignon J, Tejpar S, Canon JL, Peeters M, Rutten A, Van de Mooter T, Vermeij J, Schrijvers D, Demey W, Lybaert W, Van Huysse J, Mebis J, Awada A, Claes KBM, Hebrant A, Van der Meulen J, Delafontaine B, Bempt IV, Maetens J, de Hemptinne M, Rottey S, Aftimos P, De Grève J
Year : 2022
Journal : ESMO Open
Volume : 7
Pages : 100524

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis.

Authors : Nader-Marta G, Martins-Branco D, Agostinetto E, Bruzzone M, Ceppi M, Danielli L, Lambertini M, Kotecki N, Awada A, de Azambuja E
Year : 2022
Journal : ESMO Open
Volume : 7
Pages : 100501

Anthracyclines in the treatment of patients with early breast cancer.

Authors : Guarneri V, de Azambuja E
Year : 2022
Journal : ESMO Open
Volume : 7
Pages : 100461

Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial.

Authors : Franzoi MA, Procter M, Twelves C, Ponde N, Eiger D, Emond O, Clark E, Parlier D, Guillaume S, Reaby L, de Azambuja E, Bines J
Year : 2022
Journal : Ecancermedicalscience
Volume : 16
Pages : 1379

Timing evolution of lobular breast cancer through phylogenetic analysis.

Authors : Fimereli D, Venet D, Rediti M, Boeckx B, Maetens M, Majjaj S, Rouas G, Marchio C, Bertucci F, Mariani O, Capra M, Bonizzi G, Contaldo F, Galant C, Van den Eynden G, Salgado R, Biganzoli E, Vincent-Salomon A, Pruneri G, Larsimont D, Lambrechts D, Desmedt C, Brown DN, Rothé F, Sotiriou C
Year : 2022
Journal : EBioMedicine
Volume : 82
Pages : 104169

HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management.

Authors : Wolf S, Vercruyssen M, Cook L
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 446-453

Editorial: 'All you need is immunotherapy': a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?

Authors : Sclafani F, Hendlisz A
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 379-381

Mind the target: human epidermal growth factor receptor 2 in colorectal cancer.

Authors : Saude Conde R, Rasschaert G, Bregni G, Hendlisz A, Sclafani F
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 382-388

Psychological interventions targeting patients with metastatic cancer and prolonged survival expectancies: advances and challenges.

Authors : Righes S, Lewis F, Waroquier P, Delevallez F, Merckaert I
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 256-264

How to support parenting in patients with cancer and co-parents? From research to practice.

Authors : Liénard A, Lamal S, Merckaert I
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 285-293

Editorial: Psychological interventions in oncology: advances and challenges.

Authors : Libert Y, Merckaert I, Klastersky JA
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 253-255

Biomarkers and immunotherapy: where are we?

Authors : Langouo Fontsa M, Padonou F, Willard-Gallo K
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 579-586

Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer: Critical Analysis of Strengths, Weaknesses, and Misinterpretations.

Authors : Conforti F, Pala L, Bagnardi V, De Pas T, Colleoni M, Buyse M, Hortobagyi G, Gianni L, Winer E, Loibl S, Cortes J, Piccart-Gebhart M, Wolff AC, Viale G, Gelber Rd
Year : 2022
Journal : JAMA Oncol
Volume : 8
Pages : 1668-1675

Optic neuritis in lung adenocarcinoma: A challenging diagnosis.

Authors : Goudsmit A, Brandao M, Oullai A, Engelman D, Ghorra N, Daif T, Buelens T, Meert AP
Year : 2022
Journal : Respir Med Res
Volume : 82
Pages : 100966

Efficacy of a support intervention designed to improve parents' communication with children dealing with parental cancer: a randomized pilot trial.

Authors : Liénard A, Lamal S, Merckaert I, Razavi D
Year : 2022
Journal : Support Care Cancer
Volume : 30
Pages : 9823-9832

Understanding the Radiobiological Mechanisms Induced by (177)Lu-DOTATATE in Comparison to External Beam Radiation Therapy.

Authors : Delbart W, Karabet J, Marin G, Penninckx S, Derrien J, Ghanem GE, Flamen P, Wimana Z
Year : 2022
Journal : Int J Mol Sci
Volume : 23

Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells.

Authors : Scalia A, Kindt N, Trelcat A, Nachtergael A, Duez P, Journé F, Carlier S
Year : 2022
Journal : Int J Mol Sci
Volume : 23

Systemic therapy for early-stage breast cancer: learning from the past to build the future.

Authors : Agostinetto E, Gligorov J, Piccart-Gebhart M
Year : 2022
Journal : Nat Rev Clin Oncol
Volume : 19
Pages : 763-774